املؤمتر الدويل الرابع لجمعية امراض الدم األردنية
|
|
|
- Bertram Flynn
- 6 years ago
- Views:
Transcription
1 The 4 th International Conference of the Jordanian Society of Hematology املؤمتر الدويل الرابع لجمعية امراض الدم األردنية Jordanian Society of Hematology February 10 th - 12 th, 2016 Le Royal Hotel Amman, Jordan Organized by Jordanian Society of Hematology
2 4 The 4 th International Conference of the Jordanian Society of Hematology Topics Acute Leukemias, Chronic Leukemias, Lymphoma, Multiple Myeloma, Myelodysplastic syndrome, Benign Hematology, Bleeding and thrombotic disorders, Supportive Care Committees Dr. Salah Abbasi President of Conference President of JSH Dr. Abdullah Awidi Abbadi Vice President of JSH/ Conference Dr. Adnan Abu Rajab Treasurer Dr. Ahmad Telfah Chairman of Executive Committee Dr. Khalifa Omari Chairman of Preparatory Committee Dr. Ghadeer Abdeen Chairman of Scientific Committee Dr. Ahmad Magableh Secretary General of JSH Dr. Basem Kiswani Media Committee A Scientific Exhibition will be running throughout the days of the conference
3 The 4 th International Conference of the Jordanian Society of Hematology 5 Day I February 10 th, Registration Session I Stem Cell Therapy /MDS/ Anemia Moderators: 1) Mohammed Salameh, M.D 2) Nabil Alloush, M.D Stem Cell Therapy: Current Status Abdallah Abbadi, M.D Anemia in Cancer Patients Hikmat Abdel Razek, M.D MDS/ Anemia overlap Ghulam Mufti, M.D
4 6 The 4 th International Conference of the Jordanian Society of Hematology Session II Novartis Symposium/CML ( ) Moderators: Faek Madant, M.D CML Update Giueseppe Saglio, M.D Day II February 11 th, 2016 Session I Acute Leukemia ( ) Moderators:1) Sana Sukon, M.D 2) Eyad Arafat, M.D 3) Lina Merie, M.D Current Status And future Options In The Diagnostic And Treatment of Adult Acute lymphoblastic leukemia Including New Immunotherapy Approaches Dieter Hoelzer, M.D Acute Myeloid Leukemia: The Impact of Age Thomas Büchner, M.D Therapy of high-grade T- and B-lymphoblastic lymphoma and Burkitt lymphoma Dieter Hoelzer, M.D
5 The 4 th International Conference of the Jordanian Society of Hematology Acute Myeloid Leukemia: The Impact of Treatment Intensity Thomas Büchner, M.D Discussion Coffee Break Session II Bone Marrow Transplant /MDS ( ) Moderators:1) Khalifeh Omari, M.D 2) Omar Rawi, M.D Epidemiology, Diagnostics (molecular) And Treatment of MDS Theo de Witte, M.D Transplant In Hodgkin disease Fawzi Abdelrahman, M.D Algorithm of Treatment of Aplastic Anemia: An Update Ayad Ahmed Hussein, M.D The Role of Allogeneic Stem cell Transplantation In MDS Theo de Witte, M.D Session III Hikma Symposium / CML Update ( ) Chairman: Abdullah Abbadi, M.D
6 8 The 4 th International Conference of the Jordanian Society of Hematology How I treat CML in 2016 Carlo Gambacorti Passerini, M.D 2- Cemivil in CML Treatment in Jordan: Real World Evidence Neyla G. Darwaza, M.D Session IV Bleeding Disorders/ ITP ( ) Moderators: 1) Mousa Barqawi, M.D 2) Nazzal Bsoul, M.D Current and Future Approaches in Glanzmann s thrombasthenia Roseline d OIRON, M.D The Biology of Thrombopoietin and its Clinical Use in Hematology David Kuter, M.D Rare Bleeding Disorders Roseline d OIRON, M.D Discussion Coffee Break
7 The 4 th International Conference of the Jordanian Society of Hematology 9 Session V Novartis Symposium Myeloproliferative Disorders ( ) Moderators: Marwan Akasheh, M.D Myelofibrosis Andreas Reiter, M.D Dinner Day III February 12 th, 2016 Session I Multiple Myeloma/ Thrombosis ( ) Moderators: 1) Ahmad Telfah, M.D 2) Kamal Al Rabee, M.D First Line Therapy in Multiple Myeloma In Non-Transplant Candidate Thierry Facon, M.D Treatment of VTE with Direct Oral Anticoagulation Harry R. Büller, M.D
8 10 The 4 th International Conference of the Jordanian Society of Hematology Treatment of Relapsed Refractory Multiple Myeloma Thierry Facon, M.D Discussion Friday Prayer Session II Symposium/ Roche ( ) Moderators: Mohammed Dowairy, M.D Surviving lymphoma :The dark side of Success Alaa Addasi, M.D Lunch Session III Lymphoma ( ) Moderators: 1) Ahmad Othman, M.D 2) Mohammed Bishtawi, M.D Burkitts lymphoma :Un Update Waleed Rashid, M.D Pathological classification of Non Hodgkin Lymphoma Nidal Masri, M.D Discussion
9 The 4 th International Conference of the Jordanian Society of Hematology Coffee Break Session IV Benign Hematology ( ) Moderators: 1) Ahmad Maqableh, M.D 2) Basem Kiswani, M.D Cerebrovascular Problems in Hemoglobinopathies David Rees, M.D The Role of Revolade in the Management of ITP Adrian Newland, M.D Future Trends in Treatment of Hemoglobinopathies David Rees, M.D Discussion Moderators: Alaa Addasi, M.D Session V Immune Therapy- MSD Symposium ( ) Immunotherapy in Hematological Malignancies Mohammed Salameh, M.D Dinner
10 12 The 4 th International Conference of the Jordanian Society of Hematology Local & Regional Papers 1. Iron Deficiency in Yemeni Children with Sickle Cell Anemia/ Saeed Thabet Nasher, M.D/ Yemen 2. Characteristics of Patients with Hyperleukocytosis in Pediatrics Acute Lymphoblastic Leukemia (A.L.L.) at King Faisal Hospital and Research Center, Riyadh, Saudi Arabia/ Suleimman Al-Swedan, M.D et al. / KSA 3. Prospective study to determine the effectiveness of N-plate (Romiplostim) on ITP patients/ Manal Elhabbash, M.D et al. 4. Aberrant Antigen Expression in Jordanian Patients with Acute Leukemia: Our Experience at King Hussein Medical Center / Nabeeha Abbasi, M.D et al./khmc 5. Primary breast lymphoma case report a rare entity and literature review/ Arwa M. NADI, M,D and Ahmad Y. Magableh M.D/ Department of pathology and Department of Hemato-Oncology, Al-Bashir Hospital, Amman-Jordan
HEMATOLOGY & BLOOD TRANSFUSION
The Ninth Regional Meeting of The Lebanese Society of HEMATOLOGY & BLOOD TRANSFUSION October 1-3, 2015 Hilton Metropolitan Hotel, Beirut-Lebanon CME CREDITS Welcome Letter Dear Colleagues, I am pleased
a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation
a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation This resource has been developed to help guide you regarding the appropriate timing and conditions for a referral
REGISTRATION FORM New Trends in Hematology, Histiocytic Disorders and Transfusion Medicine Symposium 1-2 November 2016 / 1-2 Safar 1438
1 REGISTRATION FORM New Trends in Hematology, Histiocytic Disorders and Transfusion Medicine Symposium 1-2 November 2016 / 1-2 Safar 1438 Please print CLEARLY in BLOCK CAPITALS and return this form with
Scientific and Organizing Committee. LSMO Board. President of the Lebanese Society of Medical Oncology. Prof. Georges Chahine
Prof. Georges Chahine President of the Congress President of the Lebanese Society of Medical Oncology Scientific and Organizing Committee LSMO Board Dr. David Atallah Dr. Faysal El Kak Dr. Fadi Farhat
Scientific Program Venue: Le Meridien Hotel Amman October The 3 rd International Congress of the Jordanian Rheumatism Society (JRS)
2014 The 3 rd International Congress of the Jordanian Rheumatism Society (JRS) Organized by: Jordanian Rheumatism Society (JRS) In Collaboration with: British Society for Rheumatology (BSR) Scientific
July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244
July 3, 2013 The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Physician Compare Intelligent Search To Whom it May Concern, The American
The 11 th Congress of the Jordanian Society of Gastroenterology & Hepatology
2017 The 11 th Congress of the Jordanian Society of Gastroenterology & Hepatology Organized by: The Jordanian Society of Gastroenterology & Hepatology In Collaboration with: The Jordanian Association of
YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY
1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor
Recommended Timing for Transplant Consultation
REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org
The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:
Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist
Dr. Lina Assad (Syria) Dr. Magdy Soliman. Dr. Maher Fouad. Dr. May Hassaballah. Dr. Megahid Abu Elmagd. Dr. Mohammed El Assi. Dr.
Dr. Abd El Kareem Shaibani (Yemen) Dr. Adnan El Alfy (KSA) Dr. Ahmed Adam Dr. Ahmed Donia Dr. Ahmed Korie Dr. Ahmed Shokier Dr. Ahmed Shokr (Canada) Dr. Ashraf Donia Dr. Ayman Refaie Dr. Dujana Mousa(KSA)
Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen
Blood Cancers: Progress and Promise Mike Barnett & Khaled Ramadan Division of Hematology Department of Medicine Providence Health Care & UBC Blood Cancers Significant health problem Arise from normal cells
Index. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423
Clinical Policy: Donor Lymphocyte Infusion
Clinical Policy: Reference Number: PA.CP.MP.101 Effective Date: 01/18 Last Review Date: 11/16 Coding Implications Revision Log This policy describes the medical necessity requirements for a donor lymphocyte
12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization
Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,
Program Schedule Clinical Multidisciplinary Hematology & Oncology: The 16 th Annual Review
Program Schedule Clinical Multidisciplinary Hematology & Oncology: The 16 th Annual Review Friday, February 15, 2019 6:45 a.m. Registration, Breakfast and Exhibits 7:30 a.m. Welcome and Introductions SESSION
Annual Conference of the Canadian Blood and Marrow Transplant Group. June 11 to 14, 2014 The Westin Nova Scotian 1181 Hollis Street Halifax, NS
Annual Conference of the Canadian Blood Preliminary Program In conjunction with the Canadian National, Canadian Apheresis Group, Society, and Vector CBMTG Head Office Malachite Management Inc 375 West
HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint
HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Hematology MOC exam blueprint Based on feedback from physicians that MOC assessments should
Use of TPO mimetics for Indications Other Than ITP
Use of TPO mimetics for Indications Other Than ITP Mazyar Shadman, MD, MPH Discussant: Siobán Keel, MD Hematology Fellows Conference June 28, 2013 Thrombopoietin (TPO) and other c mpl ligands TPO mimetics
The 10th Congress of the Jordanian Society of Gastroenterology & Hepatology
2014 The 10th Congress of the Jordanian Society of Gastroenterology & Hepatology Organized by: The Jordanian Society of Gastroenterology & Hepatology In Collaboration with: The Pan Arab Society of Gastroenterology
MYELODYSPLASTIC AND MYELOPROLIFERATIVE
MYELODYSPLASTIC AND MYELOPROLIFERATIVE DISORDERS Pediatric Hemato-Oncology Division Medical Faculty University of Sumatera Utara 1 MYELODYSPLASIA SYNDROME A group of disorder defect in hematopoetic cell
Scientific Program April The 4 th International Congress of the Jordan Rheumatism Society (JRS) CME: 13 Hours
2017 The 4 th International Congress of the Jordan Rheumatism Society (JRS) Organized by: The Jordan Rheumatism Society (JRS) In Collaboration with: The British Society for Rheumatology (BSR) Scientific
SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Haematology. Final Written Examination 2019
SAUDI FELLOWSHIP TRAINING PROGRAM Adult Haematology Final Written Examination 2019 Examination Format: A. The Saudi fellowship specialty final written examination shall consist of one paper with 80-120
ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology
ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME approved: June 27, 2006; effective: July 1, 2007 ACGME approved focused revision: September 30, 2012; effective:
NEWS FROM. Roswell Park s LEUKEMIA SERVICE
NEWS FROM Roswell Park s LEUKEMIA SERVICE MEET THE LEUKEMIA TEAM PATHOLOGY The Leukemia Service at Roswell Park Cancer Institute () is dedicated to quality patient care, innovative research, and the development
Day 1. Thursday 25 Jan Opening Ceremony. 10:00 am - 11:30 am. 12:15 am -12:45am. 12:45 pm -14:30 pm. Moderators
Thursday 25 Jan. 2018 10:00 am - 11:30 am Opening Ceremony Day 1 12:15 am -12:45am 12:45 pm -14:30 pm Industry sponsored Satellite Symposia: The role of everolimus in HCC liver Transplantation Speaker
14th Annual Scientific Meeting. Towards A New Era of Precision Medicine
M a la y s i an S o c ie t y of H a e m a t o l o g y 14th Annual Scientific Meeting 20-22 April 2017 Holiday Villa, Johor Bahru EARLY BIRD REGISTRATION ABSTRACT SUBMISSION For registration and abstract
Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand
Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand This list provides indications for the majority of adult BMTs that are performed in New Zealand. A small number of BMTs
SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours.
SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE- Total hours number 70 hours, including course 0 hours, seminars 0 hours. Aim of the subject of Hematology: The study of etiology, pathogenesis,
Pediatric Hematology-Oncology
Pediatric Hematology-Oncology Content Outline In-Training, Initial Certification, and Maintenance of Certification Exams Effective for exams administered beginning April 1, 2019 THE AMERICAN BOARD of PEDIATRICS
Myelodyplastic Syndromes Paul J. Shami, M.D.
Myelodyplastic Syndromes Paul J. Shami, M.D. Professor of Hematology, University of Utah Member, Huntsman Cancer Institute Objectives Define Myelodysplastic Syndromes (MDS) Explain how MDS are diagnosed
Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology
Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology Faculty representative: Neil Weiner, MD Resident representative: Guiherme Rabinowits, MD Revision date: February 28, 2006 Goals
Annual Report Division of Hematology Department of Medicine, Jewish General Hospital April 1, December 31, 2011
Annual Report Division of Hematology Department of Medicine, Jewish General Hospital April 1, 2011 - December 31, 2011 I HIGHLIGHTS A) Segal Cancer Center After more than five years of operation in the
NEWS FROM. Roswell Park s LEUKEMIA SERVICE
NEWS FROM Roswell Park s LEUKEMIA SERVICE MEET THE LEUKEMIA TEAM The Leukemia Service at Roswell Park Cancer Institute (RPCI) is dedicated to quality patient care, innovative research, and the development
The program is divided into 10 sub-specialty sessions over 2 days, interspersed with posters exhibits, symposia and workshops.
SCIENTIFIC PROGRAM The program is divided into 10 sub-specialty sessions over 2 days, interspersed with posters exhibits, symposia and workshops. Artificial Intelligence (plus Research & 3D Printing) Cardiac
Saudi Fellowship Training Program. Final Written Examination of Adult Hematology 2018
Saudi Fellowship Training Program Final Written Examination of Adult Hematology 2018 Objectives: Determine the quantity and quality of a hematologist s knowledge base ranked as competent, so that the individual
Systematic Reviews in Hematological Malignancies
Systematic Reviews in Hematological Malignancies Pia Raanani, MD Davidoff Cancer Center Rabin Medical Center, Israel 1 2 Disorder CHMG Systematic review* Title Protocol Full Review Myelodysplastic syndrome
Kymriah. Kymriah (tisagenlecleucel) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.101 Subject: Kymriah Page: 1 of 5 Last Review Date: September 20, 2018 Kymriah Description Kymriah
Donor Lymphocyte Infusion for Malignancies Treated with an Allogeneic Hematopoietic Stem-Cell Transplant
Last Review Status/Date: September 2014 Page: 1 of 8 Malignancies Treated with an Allogeneic Description Donor lymphocyte infusion (DLI), also called donor leukocyte or buffy-coat infusion is a type of
King Abdulaziz Cardiac Centre, National Guard And The Saudi Heart Association
King Abdulaziz Cardiac Centre, National Guard And The Saudi Heart Association Announce : 9 th Echocardiography Workshop on Congenital Heart Disease Morphologic and Echocardiographic Correlations Revisited
ECOND ANNUAL INTERNAL MEDICINE REVIEW October Ramee Grand Hotel 26 CME CREDITS. Renowned Speakers. Days Review Program ACCREDITED BY NHRA FOR
ACCREDITED BY NHRA FOR 26 CME CREDITS ECOND ANNUAL INTERNAL MEDICINE REVIEW 4 12 Renowned Speakers Days Review Program Organizer: 2017 25-28 October Ramee Grand Hotel Manama, Kingdom www.mobilitybh.com
Trends of Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region,
Trends of Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region, 1984-2007 Syed O. A. Ahmed, 1 Ardeshir Ghavamzadeh, 2 Syed Z. Zaidi, 3 Helen Baldomero, 4 Marcelo C. Pasquini, 5 Fazal
The American Society of Hematology (ASH) represents more than 17,000 clinicians and
American Society of Hematology Statement to the House Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies FY 2020 Funding for NIH and CDC The American Society of Hematology (ASH)
1MENA PAIN CONGRESS ENA. Marriott Al Jaddaf - Dubai, U.A.E. In collaboration with Saudi Pain Society MIDDLE EAST & NORTH AFRICA
British Anaesthesia and Pain Academy Pan Arab Federation of Societies of Anesthesia, Intensive Care and Pain Management رابطة الجمعيات العربية لا طباء التخدير والعناية المركزة ومعالجة الا مل ST 1MENA MIDDLE
IMC-Transradial Intervention Symposium
IMC-Transradial Intervention Symposium Thursday 24 January 2013 15 CME Hours Accredited Main Auditorium, the International Medical Center Learning Objectives For the intervention cardiologists or his teams
BMTCN Review Course Basic Concepts and Indications for Transplantation How the Experts Treat Hematologic Malignancies Las Vegas, NV, March 10, 2016
BMTCN Review Course Basic Concepts and Indications for Transplantation How the Experts Treat Hematologic Malignancies Las Vegas, NV, March 10, 2016 David Rice, PhD, RN, NP Director, Professional Practice
LEUKEMIAS 2017 ACUTE & CHRONIC ENCORE AT WYNN LAS VEGAS LAS VEGAS, NEVADA OCTOBER 6 7, 2017
Jointly provided by Mayo School of Continuous Professional Development and Mayo Continuing Nursing Education ACUTE & CHRONIC LEUKEMIAS 2017 REGISTER NOW! $75 DISCOUNT For Early Registration Expires 9/6/2017
Actinium Pharmaceuticals Highlights Analysis of Pivotal Iomab-B Phase 3 SIERRA Trial Presented in Oral Session at ASH Annual Meeting
December 4, 2018 Actinium Pharmaceuticals Highlights Analysis of Pivotal Iomab-B Phase 3 SIERRA Trial Presented in Oral Session at ASH Annual Meeting - Key highlights include near universal engraftment
PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019
MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments
Dr.PSRK.Sastry MD, ECMO
Peripheral blood stem cell transplantation (Haematopoietic stem cell transplantation) Dr.PSRK.Sastry MD, ECMO Consultant, Medical Oncology Kokilaben Dhirubhai Ambani Hospital Normal hematopoiesis Historical
Dear Colleagues, Sana Al Sukhun, MD, MSc. JOS president.
Dear Colleagues, On behalf of the Jordanian Oncology Society Executive Committee, it is my pleasure to welcome you to the "Highlights of ASCO " conference at the Movenpick Dead Sea Hotel. We will be reviewing
2018 UPDATE IN HEMATOLOGIC MALIGNANCIES with Proceedings from International Medical Meetings
FRIDAY, JANUARY 26, 2018 7:30 AM 4:30 PM Hilton Philadelphia City Avenue 4200 City Avenue Philadelphia, PA 19131 Penn Medicine s Abramson Cancer Center and the Leukemia & Lymphoma Society PRESENT 2018
19 th December Time: 08:30am 11:30 am
38 th Annual KEMCAANA Scientific Symposium 19 th December 2018 Time: 08:30am 11:30 am Hall A HALL B Venue Library Hall Patiala Block Audiovisual Theater KEMU Patiala Block Chairperson Prof. Mahmood Ali
Comparing outcome between Belgian haematopoietic stem cell transplant centres
ENCR2016, 2014/06/10 1 Comparing outcome between Belgian haematopoietic stem cell transplant centres Gilles Macq 1, Evelien Vaes 1, Geert Silversmit 1, Marijke Vanspauwen 1, Liesbet Van Eycken 1 & Yves
Index. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abdominal tumors, in children, 530 531 Alkalinization, in tumor lysis syndrome, 516 Allopurinol, in tumor lysis syndrome, 515 Anaphylaxis, drug
DAY 1 12 MARCH 2018 MAIN LECTURE FIRST SESSION FORESIGHTING THE FUTURE SCOPE H.E. MARWAN AHMED AL SAWALEH
DAY 1 12 MARCH 2018 OPENING CEREMONY 10:00-10:03 The National Anthem of the United Arab Emirates 10:03-10:05 Holy Quran 10:05-10:10 Short Documentary about International Hemaya Forum 10:10-10:20 Opening
Johns Hopkins Aramco Healthcare International Stroke Conference
Johns Hopkins Aramco Healthcare International Stroke Conference October 10-12, 2015 Le Meridien Hotel Khobar, Saudi Arabia 23 Credit Hours by SCHS/ 25.25 AMA Category 1 Credit Hours WELCOME Welcome to
Original Article. Clinical features and outcome of acute myeloid leukemia, a single institution experience in Saudi Arabia INTRODUCTION
Original Article Clinical features and outcome of acute myeloid leukemia, a single institution experience in Saudi Arabia Ahmed Al Faleh 4, Abdullah Al-Quozi 2,3,4, Ahmed Alaskar 1,3,4, Mohsen Al Zahrani
ASPHO 2019 Review Course January 31-February 2, 2019
ASPHO 2019 Review Course January 31-February 2, 2019 ABP Content Outline Topics by Date and Speaker For additional information, see the ABP Content Outline and the ABP Content Outline with Speaker Assignments.
2019 UPDATES IN CARE OF THE HEMATOLOGIC MALIGNANCIES PATIENT: with Proceedings from International Medical Meetings
Continuing Medical and Interprofessional Education FRIDAY, FEBRUARY 1, 2019 7:30 AM - 4:30 PM The Rittenhouse Hotel 210 W Rittenhouse Square Philadelphia, PA 19103 Penn Medicine s Abramson Cancer Center
An Introduction to Bone Marrow Transplant
Introduction to Blood Cancers An Introduction to Bone Marrow Transplant Rushang Patel, MD, PhD, FACP Florida Hospital Medical Group S My RBC Plt Gran Polycythemia Vera Essential Thrombocythemia AML, CML,
Company Overview. January 2019
Company Overview January 2019 1 Disclaimer This Presentation includes certain projections and forward-looking statements as of the date of this Presentation provided by Gamida Cell Ltd (the Company ).
5/9/2018. Bone marrow failure diseases (aplastic anemia) can be cured by providing a source of new marrow
5/9/2018 or Stem Cell Harvest Where we are now, and What s Coming AA MDS International Foundation Indianapolis IN Luke Akard MD May 19, 2018 Infusion Transplant Conditioning Treatment 2-7 days STEM CELL
Stem Cell Transplantation for Severe Aplastic Anemia
Number of Transplants 10/24/2011 Stem Cell Transplantation for Severe Aplastic Anemia Claudio Anasetti, MD Professor of Oncology and Medicine Chair, Blood and Marrow Transplant Dpt Moffitt Cancer Center
Technical Bulletin No. 100
CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 100 August 2, 2012 JAK2 AND MPL 515 MUTATIONAL ANALYSIS Contact: Dr. Jeffrey Wisotzkey, 717-851-1422 Technical Director, CPAL Jill A.
[COMPREHENSIVE GENETIC ASSAY PANEL ON
2014 SN GENELAB AND RESEARCH CENTER DR. SALIL VANIAWALA, PH.D [COMPREHENSIVE GENETIC ASSAY PANEL ON MYELOPROLIFERATIVE NEOPLASMS] SN Genelab presents one of the most comprehensive genetic assay panel for
JANUARY 22, :00 AM 4:30 PM
FRIDAY, JANUARY 22, 2016 8:00 AM 4:30 PM Hilton Hotel 4200 City Avenue Philadelphia, PA 19131 Penn Medicine s Abramson Cancer Center and the Leukemia & Lymphoma Society PRESENT UPDATE IN HEMATOLOGIC CANCERS
Practical Diagnosis of Hematologic Disorders. Vol 2 Malignant Disorders
5 th ed Practical Diagnosis of Hematologic Disorders Vol 2 Malignant Disorders Vol2_FrontMatter_v03_0804 final.indd i 8/6/2009 10:00:11 PM Authors Carl R Kjeldsberg, MD Professor of Pathology, University
DEPARTMENT OF CLINICAL HEMATOLOGY
DEPARTMENT OF CLINICAL HEMATOLOGY What is blood? Blood is the vital fluid of the body, which performs diverse functions from delivering oxygen to each and every cell of the body to fighting against infections
Tasigna. Tasigna (nilotinib) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.77 Subject: Tasigna Page: 1 of 6 Last Review Date: March 16, 2018 Tasigna Description Tasigna (nilotinib)
9 th - 11 th of March nd Jordan JFDA International Congress
2 nd announcement 9 th - 11 th of March 2018 Fairmont Amman Hotel (Amman-Jordan) Preconference workshop on March 9 th, 2018 www.jfda.jo 2 nd Jordan JFDA International Congress المو تمر الدولي الثاني للمو
HEMATOLOGY MODULE STUDY GUIDE Course Title Hematology Module B Course Coordinator: Dr. Irfan Ashraf
HEMATOLOGY MODULE STUDY GUIDE A Course Title Hematology Module B Course Coordinator: Dr. Irfan Ashraf C Course Committee Dr. Irfan Ashraf, Dr. Syeda Zarreen Raza, Dr. Rubia Kashif D Objectives of Study
Adult Acute leukemia. Matthew Seftel. August
Adult Acute leukemia Matthew Seftel August 21 2007 mseftel@cancercare.mb.ca Principles 3 cases Diagnosis and classification of acute leukemia (AL) Therapy Emergencies Remission induction BMT Complications
Tasigna. Tasigna (nilotinib) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.77 Subject: Tasigna Page: 1of 5 Last Review Date: September 15, 2017 Tasigna Description Tasigna (nilotinib)
THE EGYPTIAN SOCIETY FOR THE GLAUCOMAS
Fourteenth Annual Congress of THE EGYPTIAN SOCIETY FOR THE GLAUCOMAS 30-31 October 2014 Le Meridien Heliopolis, Cairo, Egypt SCIENTIFIC PROGRAM Dear Colleagues: On behalf of the board members of the Egyptian
Contents SECTION 1: PHYSIOLOGY OF BLOOD
Contents SECTION 1: PHYSIOLOGY OF BLOOD Chapter 1: Overview of Physiology of Blood 1 Normal Haematopoiesis 1 Red Blood Cells 6 White Blood Cells 15 Immune System 27 Megakaryopoiesis 32 Normal Haemostasis
CONFERENCE AGENDA (Subject to Change)
Thursday, August 9, 2018 7:00 am 5:30 pm Registration Desk Open 8:00 am 8:10 am Welcome and Announcements 8:10 am 9:00 am Best of ASCO Session 1 Genitourinary Cancer 9:00 am 9:50 am Best of ASCO Session
An Overview of Blood and Marrow Transplantation
An Overview of Blood and Marrow Transplantation October 24, 2009 Stephen Couban Department of Medicine Dalhousie University Objectives What are the types of blood and marrow transplantation? Who may benefit
Regence. Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT REMINDER
Regence Medicare Advantage Policy Manual Policy ID: M-TRA45 Stem Cell / Bone Marrow Transplants Published: 10/01/2018 Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT
Cynthia Fata, MD, MSPH 6/23/15
Cynthia Fata, MD, MSPH 6/23/15 Clinical case presentation Introduction to thrombopoietin Development of thrombopoietic agents Clinical Indications Eltrombopag use in aplastic anemia Future uses 33 yo F
Stem Cells And The Future of Regenerative Medicine. Dipnarine Maharaj, M. D., FACP
Stem Cells And The Future of Regenerative Medicine Dipnarine Maharaj, M. D., FACP The following potential conflict of interest relationships are germane to my presentation. Employment: South Florida Bone
NEPHROLOGY. The XI th Update in. October , Hilton Habtoor Hotel, Beirut-Lebanon Program. lsnh-online.org
The XI th Update in NEPHROLOGY In collaboration with Société Francophone de Néphrologie Dialyse et Transplantation Jordan Society of Nephrology and Renal Transplantation Iraqi Society of Nephrology and
Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP
Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS
EGHC. dubai Emirates Gastroenterology & Hepatology Conference. 3-5 April eghc2014.com
eghc2014.com 3-5 April 2014 Dubai Word Trade Center, Dubai, UAE This course is endorsed by the American Society for Gastrointestinal Endoscopy Welcome Note Dear Colleagues, On behalf of the EGHC 2014 Organizing
LEUKEMIA AND LYMPHOMA
J O N AT H A N W O O D & A S S O C I A T E S An MDedge Company LEUKEMIA AND LYMPHOMA Europe and the US Linking Knowledge and Practice 3-5 October 2018 DUBROVNIK Valamar Lacroma Dubrovnik Hotel Dubrovnik,
Outreach Program; Sohag Course December 5 th to 7th, 2013 (ERA-EDTA Endorsed Activity)
Egyptian Society of Nephrology and Transplantation (ESNT) Outreach Program; Sohag Course December 5 th to 7th, 2013 (ERA-EDTA Endorsed Activity) A. Adult Nephrology Course Thursday December 5 th, 2013
3 rd Berlin Cancer Retreat - Agenda
3 rd Berlin Cancer Retreat - Agenda Wednesday, 5 October 2016 8:30 9:00 Registration 9:00 9:10 Welcome and Introduction Program Exploitation of Oncogenic Mechanisms Ulrike Stein 9:10 9:25 Targeting Myc
2013 Pathology Student
About this guide If you re reading this introduction, it means you are probably either a) covering hematopathology in your pathology class right now, or b) studying for boards. Either way, you ve come
HEMATOLOGIC MALIGNANCIES BIOLOGY
HEMATOLOGIC MALIGNANCIES BIOLOGY Failure of terminal differentiation Failure of differentiated cells to undergo apoptosis Failure to control growth Neoplastic stem cell FAILURE OF TERMINAL DIFFERENTIATION
Research Article Myeloid Sarcoma: Clinicopathologic, Cytogenetic, and Outcome Analysis of 21 Adult Patients
SAGE-Hindawi Access to Research Leukemia Research and Treatment Volume 2011, Article ID 523168, 4 pages doi:10.4061/2011/523168 Research Article Myeloid Sarcoma: Clinicopathologic, Cytogenetic, and Outcome
5 th Egyptian Annual Dialysis Conference
5 th Egyptian Annual Dialysis Conference 24 th -26 th October 2013 Novotel Cairo Airport Hotel - Cairo Cairo, Egypt ESNT-President Prof. Tarek Al-Baz (ESNT President) Conference Secretary Prof. Mohamed
Haematopoietic stem cell transplantation (SCT)
HAEMATOPOIETIC TEM CELL TRANPLANTATION FOR CHILREN IN BELGIUM Marie-Françoise resse 1 & Yves Beguin 2 1 epartment of Paediatrics, ivision of Hemato-Oncology, UHOPL, University of Liege, Liège, Belgium;
7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour
7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic
Stem cells. -Dr Dinesh Bhurani, MD, DM, FRCPA. Rajiv Gandhi Cancer Institute, Delhi, -Director, Department of Haematology and BMT
Stem cells -Dr Dinesh Bhurani, MD, DM, FRCPA -Director, Department of Haematology and BMT Rajiv Gandhi Cancer Institute, Delhi, Flow of presentation Update on stem cell uses Haematopoietic stem cell transplantation
Hematology Page 1 of 8
Hematology Page 1 of 8 Hematology Major Category Code Headings Revised 12/17 1 Basic methodology and test armamentarium 20000 2 Normal hematopoiesis & hemostasis 20100 3 RBC disorders, non-neoplastic 20340
Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths
RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected
VENUE & ACCOMMODATION:
THIS COURSE IS: A 5-day learning event, full immersion, clinically-oriented, multidisciplinary, directed by a selected international and national faculty of experts in oncology. ORGANIZERS: Zhianawa Cancer
PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION
PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION ROTATION TITLE Outpatient Adult Oncology PURPOSE The outpatient oncology service will provide the PGY-2 resident with the opportunity to further develop and